REFERENCES
1. Patel MR, Calhoon JH, Dehmer GJ, et al.
ACC/AATS/AHA/ASE/ASNC/SCAI/SCCT/STS 2016 Appropriate Use Criteria for
Coronary Revascularization in Patients With Acute Coronary Syndromes: A
Report of the American College of Cardiology Appropriate Use Criteria
Task Force, American Association for Thoracic Surgery, American Heart
Association, American Society of Echocardiography, American Society of
Nuclear Cardiology, Society for Cardiovascular Angiography and
Interventions, Society of Cardiovascular Computed Tomography, and the
Society of Thoracic Surgeons. J Am Coll Cardiol 2017;69(5):570-591.
2. Wiviott SD, Braunwald E, McCabe CH, et al. Prasugrel versus
clopidogrel in patients with acute coronary syndrome. N Engl J Med
2007;357:2001-15.
3. Schoergenhofer C, Hobl EL, Staudinger T, et al. Prasugrel in
critically ill patients. Thromb Haemost 2017;117(8):1582-1587.
4. Wiviott SD, Antman EM, Braunwald E. Prasugrel. Circulation
2010;122(4):394-403.
5. Yu PJ, Cassiere HA, Dellis SL, Manetta F, Stein J, Hartman AR. P2Y12
platelet function assay for assessment of bleeding risk in coronary
artery bypass grafting. J Card Surg 2014;29(3):312-6.
6. Agarwal S. Platelet function testing in cardiac surgery. Transfus Med
2016;26(5):319-329.
7. Rafiq S, Johansson PI, Kofoed KF, Olsen PS, Steinbrüchel DA.
Preoperative hemostatic testing and the risk of postoperative bleeding
in coronary artery bypass surgery patients. J Card Surg
2016;31(9):565-71.
8. Hansson EC, Jeppsson A. Antiplatelet Therapy, Platelet Function
Testing, and Bleeding Complications in Cardiac Surgery Patients. Semin
Thromb Hemost 2017;43(7):699-705.
9. Fiore M, Horovitz A, Pons AC, Leroux L, Casassus F. First report of a
subacute stent thrombosis in a prasugrel resistant patient successfully
managed with ticagrelor. Platelets 2014;25(8):636-8.
10. Alexopoulos D, Panagiotou A, Xanthopoulou I, et al. Antiplatelet
effect of prasugrel vs. double clopidogrel in patients on hemodialysis
and with high on-treatment platelet reactivity. J Thromb Haemost
2011;9:2379-2385.
11. Franken CC, Kaiser AF, Kruger JC, Overbeck K, Mügge A, Neubauer H.
Cytochrome P450 2B6 and 2C9 genotype polymorphism – A possible cause of
prasugrel low responsiveness. Thrombos Haemost 2013;110:131-140.
12. Price MJ, Walder JS, Baker BA, et al. Recovery of platelet function
after discontinuation of prasugrel or clopidogrel maintenance dosing in
aspirin-treated patients with stable coronary disease: the recovery
trial. J Am Coll Cardiol 2012;59:2338-2343.
13. Li YG, Ni L, Brandt JT, Small DS, Payne CD, Ernest
CS2nd, Rohatagi S, Farid NA, Jakubowski JA, Winters
KJ. Inhibition of platelet aggregation with prasugrel and clopidogrel:
an integrated analysis in 846 subjects. Platelets 2009;20(5):316-27.
14. Mannacio V, Meier P, Antignano A, Di Tommaso L, De Amicis V, Vosa C.
Individualized strategy for clopidogrel suspension in patients
undergoing off-pump coronary surgery for acute coronary syndrome: a
case-control study. J Thorac Cardiovasc Surg 2014;148:1299-1306.